Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.8%

172 terminated/withdrawn out of 2956 trials

Success Rate

92.6%

+6.0% vs industry average

Late-Stage Pipeline

8%

242 trials in Phase 3/4

Results Transparency

44%

937 of 2145 completed trials have results

Key Signals

321 recruiting937 with results98 terminated74 withdrawn

Enrollment reporting

Analytics

N/A
1319(49.4%)
Phase 2
510(19.1%)
Phase 1
355(13.3%)
Phase 4
125(4.7%)
Phase 3
117(4.4%)
Phase 1/2
94(3.5%)
Early Phase 1
92(3.4%)
Phase 2/3
58(2.2%)
2670Total
N/A(1319)
Phase 2(510)
Phase 1(355)
Phase 4(125)
+4 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2956)

Showing 20 of 2956 trials
NCT03912194Phase 3Active Not Recruiting

Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation

Role: collaborator

NCT04648228Not ApplicableActive Not Recruiting

Pain and Opioids: Integrated Treatment In Veterans

Role: collaborator

NCT05571917Not ApplicableActive Not Recruiting

Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial

Role: collaborator

NCT06561828Early Phase 1Recruiting

Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making

Role: lead

NCT06577454Not ApplicableSuspended

Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder

Role: lead

NCT06676059Recruiting

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

Role: lead

NCT06860607Phase 1Recruiting

Environment and Alcohol: A Pilot Study

Role: lead

NCT06868914Phase 1Not Yet Recruiting

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

Role: lead

NCT06995885Enrolling By Invitation

Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl

Role: lead

NCT07099092Early Phase 1Not Yet Recruiting

Causal Mechanisms of Odor-Guided Behavior in Humans

Role: lead

NCT07128485Not ApplicableNot Yet Recruiting

Remote Intervention to Prevent Overdose

Role: collaborator

NCT07637669Recruiting

Olfactory Function and Model-Based Behavior in People Living With HIV and SUD

Role: lead

NCT00787423Completed

Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatient Treatment Population

Role: lead

NCT01036685Completed

Cognitive Task Development and Implementation for Functional MRI Studies

Role: lead

NCT01867411Completed

Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity

Role: lead

NCT04783558Not ApplicableActive Not Recruiting

Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women

Role: collaborator

NCT05707806Recruiting

Development and Validation of Learning and Decision-Making Tasks

Role: lead

NCT07902752Phase 2Not Yet Recruiting

Oxytocin for Respiratory Compromise and Hypoventilation Induced by Drugs

Role: collaborator

NCT05146167Not ApplicableCompleted

Feasibility Testing a Meditation App for Youth in the Legal System

Role: collaborator

NCT05712707Phase 1/2Active Not Recruiting

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Role: collaborator